College of Healthcare Sciences, Building 043-114, James Cook University, Townsville, Queensland 4811, Australia.
College of Healthcare Sciences, James Cook University, Cairns, Queensland 4878, Australia.
Physiotherapy. 2020 Mar;106:174-193. doi: 10.1016/j.physio.2019.04.003. Epub 2019 May 2.
To investigate the effect of exercise on high-level mobility (i.e. mobility more advanced than independent level walking) in individuals with neurodegenerative disease.
A systematic literature search was conducted in Medline, CINAHL, Scopus, SportDiscus and PEDro.
Randomised controlled trials of exercise interventions for individuals with neurodegenerative disease, with an outcome measure that contained high-level mobility items were included. High-level mobility items included running, jumping, bounding, stair climbing and backward walking. Outcome measures with high-level mobility items include the High Level Mobility Assessment Tool (HiMAT); Dynamic Gait Index; Rivermead Mobility Index (RMI) or modified RMI; Functional Gait Assessment and the Functional Ambulation Category.
Quality was evaluated with the Cochrane Risk of Bias Tool.
Twenty-four studies with predominantly moderate to low risk of bias met the review criteria. High-level mobility items were included within primary outcome measures for only two studies and secondary outcome measures for 22 studies. Eight types of exercise interventions were investigated within which high-level mobility tasks were not commonly included. In the absence of outcome measures or interventions focused on high-level mobility, findings suggest some benefit from treadmill training for individuals with multiple sclerosis or Parkinson's disease. Progressive resistance training for individuals with multiple sclerosis may also be beneficial. With few studies on other neurodegenerative diseases, further inferences cannot be made.
Future studies need to specifically target high-level mobility in the early stages of neurodegenerative disease and determine the impact of high-level mobility interventions on community participation and maintenance of an active lifestyle. Systematic review registration number PROSPERO register for systematic reviews (registration number: CRD42016050362).
研究运动对神经退行性疾病患者高水平移动能力(即比独立行走更高级的移动能力)的影响。
在 Medline、CINAHL、Scopus、SportDiscus 和 PEDro 中进行了系统的文献检索。
纳入了针对神经退行性疾病患者的运动干预随机对照试验,其结果测量包含高水平移动项目。高水平移动项目包括跑步、跳跃、跳跃、爬楼梯和倒退行走。包含高水平移动项目的结果测量包括高级移动评估工具(HiMAT);动态步态指数;Rivermead 移动指数(RMI)或改良 RMI;功能性步态评估和功能性步行类别。
使用 Cochrane 偏倚风险工具评估质量。
符合审查标准的 24 项研究具有中等到低偏倚风险。只有两项研究将高水平移动项目纳入主要结果测量,22 项研究将其纳入次要结果测量。在八种运动干预类型中,并未普遍包含高水平移动任务。由于缺乏针对高水平移动的结果测量或干预措施,研究结果表明,跑步机训练对多发性硬化症或帕金森病患者可能有益。对多发性硬化症患者进行渐进式抗阻训练也可能有益。由于其他神经退行性疾病的研究较少,因此无法进一步推断。
未来的研究需要在神经退行性疾病的早期阶段专门针对高水平移动能力,并确定高水平移动干预对社区参与和保持积极生活方式的影响。系统评价注册号 PROSPERO 为系统评价注册(注册号:CRD42016050362)。